AiHuiShou Intl

AiHuiShou International Co Ltd is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform.

AiHuiShou International Co. Ltd. American Depositary Shares (every three of which representing two Class A ordinary shares)

Shares of FormFactor (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FORM#NASDAQ">FORM</a>) moved higher&nbsp;after the company reported Q2 results.
<h2>Quarterly Results</h2>
Earnings per share rose 9.09% year over year to $0.36, which beat the estimate of $0.33.
Revenue of $188,076,000 rose by 19.17% from the same period last year, which beat the estimate of $185,790,000.
<h2>Guidance</h2>
Earnings guidance hasn&#39;t been issued by the company for now.
Revenue guidance hasn&#39;t been issued by the company for now.
<h2>How To Listen To The Conference Call</h2>
Date: Jul 28, 2021
Time: 04:25 PM
ET Webcast URL: <a href="https://edge.media-server.com/mmc/p/ceecwoyo" title="https://edge.media-server.com/mmc/p/ceecwoyo">https://edge.media-server.com/mmc/p/ceecwoyo</a>
<h2>Technicals</h2>
52-week high: $52.39
Company&#39;s 52-week low was at $22.37
Price action over last quarter: down 7.27%
<h2>Company Profile</h2>
FormFactor Inc designs, develops, manufactures, sells, and supports advanced semiconductor probe card products. The company operates in two reportable segments namely Probe Cards Segment and the Systems Segment. Sales of probe cards and analytical probes are included in the Probe Cards Segment, while sales of probe stations and thermal sub-systems are included in the Systems Segment. Probe cards generate the maximum revenue from its operations. It offers multiple product lines which include analytical probes, probe stations, thermal sub-systems, and related services.

Earnings

FORM

Recap: FormFactor Q2 Earnings

News

Management

XPO Logistics Announced The Appointment Of Ravi Tulsyan As Chief Financial Officer Effective September 2, 2021

Monarch Casino &amp; Resort (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MCRI#NASDAQ">MCRI</a>) reported quarterly earnings of $0.93 per share. This is a 487.5 percent increase over losses of $(0.24) per share from the same period last year. The company reported $97.70 million in sales this quarter. This is a 544.63 percent increase over sales of $15.16 million the same period last year.

MCRI

Monarch Casino & Resort Q2 EPS $0.93 Up From $(0.24) YoY, Sales $97.70M Up From $15.16M YoY

Churchill Downs (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CHDN#NASDAQ">CHDN</a>) reported quarterly earnings of $3.08 per share which beat the analyst consensus estimate of $2.52 by 22.22 percent. This is a 681.13 percent increase over losses of $(0.53) per share from the same period last year. The company reported quarterly sales of $515.10 million which beat the analyst consensus estimate of $478.63 million by 7.62 percent. This is a 178.28 percent increase over sales of $185.10 million the same period last year.

CHDN

Churchill Downs Q2 Adj. EPS $3.08 Beats $2.52 Estimate, Sales $515.10M Beat $478.63M Estimate

Dividends

Marathon Petroleum Group Announced It Has Declared A Quarterly Dividend Of $0.58 Per Share On Common Stock Payable September 10, 2021 To Shareholders Of Record As The Close Of Business On August 18, 2021

Guidance

NUVA

NuVasive Sees FY21 Net Sales $1.19B-$1.21B Vs $1.2B Est.; Sees Non-GAAP EPS $2.25-$2.35 Vs $2.20 Est.

SPOK

Spok Reaffirms FY21 Guidance For Sales $138M-$151M

Service Corp International Raises FY21 EPS Guidance From $2.70-$3.00 To $3.20-$3.50 vs $2.89 Est.

There&rsquo;s no sign of the Fed switching off the auto-pilot button as it emerges from today&rsquo;s meeting.
Rates remained unchanged at basically zero, and the Fed remains accommodative with no plans to stop its $120 billion in monthly bond purchases anytime soon. In general, this Federal Open Market Committee (FOMC) meeting was kind of a placeholder for the Fed, and also didn&rsquo;t bring any updates in its economic forecast.&nbsp;
Rising prices &ldquo;largely reflect transitory factors,&rdquo; the Fed said. Sounds familiar. The Fed sees improvement in the economy coming out of the pandemic, but says we&rsquo;re not all the way back yet, especially in the sectors that suffered most. Also very much in line with its previous statements.&nbsp;
Treasury yields were relatively flat and major stock indices were mixed before the Fed announcement and stayed that way immediately afterward. However, sometimes the market can move when Fed Chairman Jerome Powell speaks, so his press conference today might have an impact. Major indices did seem to move higher as he spoke, perhaps reacting to the fact that he didn&rsquo;t say anything that sounded too hawkish.&nbsp;
Speaking in a press conference right after the meeting, Powell shared some views on the economy, saying the housing market and business investment remain strong and conditions in the labor market continue to improve. Supply constraints in the auto industry are &ldquo;particularly acute,&rdquo; he added.&nbsp;
&ldquo;Supply bottlenecks have been stronger than anticipated,&rdquo; Powell said. &ldquo;But as they abate,&rdquo; he expects inflation to drop toward the Fed&rsquo;s long-term goal. The &ldquo;base effects&rdquo; of comparing prices now to very low prices a year ago during the crisis, as well as the effect from high energy prices, are both receding, he said.&nbsp;
The Fed wants to keep long-term inflation expectations near its 2% goal, Powell said. If the Fed saw that starting to rise, that would potentially be one thing that could affect its policy stance.
Powell still sees challenges in the labor market. &ldquo;The 5.9% unemployment rate actually understates unemployment,&rdquo; due to low job market participation, he said. This could reflect trouble people are having finding caretakers, along with fears of the virus. &ldquo;These should ease in coming months, leading to strong employment growth,&rdquo; Powell said.&nbsp;
One interesting note in the press conference was Powell making a pretty definitive statement about the price environment.&nbsp;
&ldquo;We won&rsquo;t have an extended period of high inflation,&rdquo; Powell said. &ldquo;Some will fall away as the process of reopening the economy moves through over time.&rdquo;&nbsp;
He said the near-term inflation risk is &ldquo;to the upside&rdquo; but has confidence that will be less of the case in the medium term.&nbsp;
<h2>Stuck In The Middle Again</h2>
Approaching the Fed meeting, it really felt like Powell and company were between a proverbial rock and a hard place.&nbsp;
On the one hand, the inflation numbers keep going up and the heat index on the economy remains high. Analysts expect Q2 gross domestic product&mdash;due Thursday&mdash;to show better than 8% growth, according to a consensus from research firm Briefing.com. Earnings growth so far this quarter is through the roof, with FactSet predicting it to rise more than 70% year over year. June saw more than 800,000 jobs created, the U.S. government reported, and retail sales are sizzling.&nbsp;
All those are possible signs of a surging economy that may need some Fed cooling. On the other hand, unemployment remains stubbornly high, most analysts expect economic and earnings growth to slow substantially in 2022, and the housing market is showing signs of heat exhaustion. The stock market had a big hiccup earlier this month when it suddenly seemed to notice the rise in cases of the Delta variant of Covid spreading around the country.&nbsp;
Because things seem so even-steven, the Fed&rsquo;s so far kept its transmission in neutral, declining to take any steps to curb the virtually zero-level interest rates or $120 billion a month in bond buying it began at the start of the pandemic.&nbsp;
There was a bit of a window in June, at the Fed&rsquo;s last meeting when it appeared there might be a slight chance of the Fed hitting the brake pedal. Back then, Powell said it&rsquo;s fair to say the Fed is &ldquo;thinking about thinking about&rdquo; tapering its stimulus. But that was more than 40 days ago at a time when Covid cases were approaching a post-pandemic low and inflation metrics were sharply higher several months in a row. The market suffered a slight hiccup after that meeting, which may be instructive as this week continues if the Fed seems to lean at all hawkish.&nbsp;
Approaching the meeting today, most analysts on Wall Street were thinking the Fed might announce terms and timing of a taper perhaps at its Jackson Hole conference late next month or at its regular meeting in late September. That&rsquo;s where we are now: The big news isn&rsquo;t any specific Fed action, but instead looking for hints of when the Fed might announce the timing of future action. Powell&rsquo;s press conference didn&rsquo;t really give much more color on the timing.&nbsp;
As the Fed remains accommodative, the bond market shows no real signs of pushing the Fed into any anti-inflationary action. Though the 10-year Treasury yield has bounced back from six-month lows posted last week, its current level near 1.26% is historically low and down 50 basis points from highs earlier this year. In part, this may reflect investors piling into U.S. fixed income markets because they offer better yield than overseas&rsquo; fixed income instruments.&nbsp;
It also could be read as a sign of investors generally believing the Fed when it says inflation will ease. The next inflation update comes Friday with Personal Consumption Expenditure (PCE) prices for June.
Something else investors might have been looking for from Powell today is any sign that he&rsquo;s worried about a slowing economy due to the Delta variant of Covid. That&rsquo;s the kind of dovish stuff that might lift stocks, with bad news basically becoming &ldquo;good news,&rdquo; at least in the sense that there&rsquo;d be less fear of the Fed getting ready to tighten things. Powell noted the pace of vaccinations has slowed and thinks a faster pace would get the economy back to normal more quickly.
<a href="https://tickertapecdn.tdameritrade.com/assets/images/pages/lg/10-year-treasury-yields-support-mu7-28.jpg"><img alt="philadelphia semiconductor index" src="https://tickertapecdn.tdameritrade.com/assets/images/pages/md/10-year-treasury-yields-support-mu7-28.jpg" style="height:331px; width:640px" /></a>
CHART OF THE DAY:&nbsp;SMALL BOUNCE IN YIELDS.&nbsp;After hitting a low last week, which took the 10-year Treasury yield (TNX&mdash;candlestick) pretty close to its 50% Fibonacci retracement level (yellow horizontal line), TNX has bounced back a bit. It didn&rsquo;t move much after the Fed&rsquo;s decision to keep rates unchanged. Data source: Cboe Global Markets.&nbsp;Chart source: The&nbsp;<a href="https://www.tdameritrade.com/tools-and-platforms/thinkorswim.page">thinkorswim&reg; platform</a>.&nbsp;For illustrative purposes only. Past performance does not guarantee future results.&nbsp;&nbsp;
Claim Jumping:&nbsp;Tomorrow morning&rsquo;s initial unemployment claims may get more attention than usual following the Fed&rsquo;s meeting and the previous data point that came in way above expectations. Consensus on Wall Street is for initial claims to total 375,000, according to research firm Briefing.com. That would be down from a surprising jump to 419,000 last time, which was the highest reading since mid-May and way above expectations. So the question going into tomorrow is whether that swollen number was a one-timer or something more pernicious.&nbsp;
Judging from the average estimate of 375,000 going into Thursday&rsquo;s data, it looks like Wall Street analysts don&rsquo;t think a new upward trend has started. The thing to consider, whatever tomorrow&rsquo;s number might be, is to keep an eye on the four-week average, which tends to smooth out any bumps and bruises. It was 385,000 last week, which is still way above levels typically seen before the pandemic. As much as claims have fallen over the course of the year, it doesn&rsquo;t feel like we&rsquo;re getting back to the below-300,000 a week average seen for years going into Covid.
Strength In&nbsp;&ldquo;Cyclicals&rdquo; Leads Earnings Growth:&nbsp;You may be hearing how strong earnings season has been as we approach the halfway point, but it&rsquo;s also interesting to see where the strength is concentrated. So far, it&rsquo;s so-called &ldquo;cyclical&rdquo; sectors at the head of the class. A reminder that cyclical sectors are ones like Industrials, Materials, and Energy that tend to do better during times of rebounding economic growth.&nbsp; Industrials are holding up their end of the bargain, with companies in that sector reporting an off-the-charts average earnings growth of more than 600% from a year ago, according to Refinitiv data. Energy earnings are up 225% through Monday, and Materials are up 126%.&nbsp;
Another strong category is Consumer Discretionary, up nearly 300% year-over-year. Some of this might reflect relatively easy comparisons to a year-ago period when earnings cratered during the pandemic lockdowns. That&rsquo;s one reason why many analysts think Q2 could represent the peak of post-pandemic earnings growth. That&rsquo;s not to say earnings can&rsquo;t keep growing, but just at a slower pace. Analysts see Q3 earnings growing 27.6%, still a very high level but down sharply from the anticipated 78.4% growth in Q2, according to Refinitiv.
Inflation Thoughts:&nbsp;One thing to keep in mind with the current high inflation, by the way, is that inflation trended well below the Fed&rsquo;s 2% target for many years before the current pricing pressures began.
Also, the Fed has said it&rsquo;s willing to let inflation run high for a while to not risk squeezing the economy as it emerges from the Covid recession. In one sense, everyone is getting excited about a few months of high inflation, but you&rsquo;ve got to take into account the years of abnormally low inflation that preceded this. On average, inflation remains low overall during the last half a decade or so.
TD Ameritrade&reg; commentary for educational purposes only. Member SIPC.
Image by <a href="https://pixabay.com/users/cegoh-94852/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=3184798">Jason Goh</a> from <a href="https://pixabay.com/?utm_source=link-attribution&amp;utm_medium=referral&amp;utm_campaign=image&amp;utm_content=3184798">Pixabay</a>

Bonds

Commodities

Treasuries

Federal Reserve

Markets

General

Fed Sticks To Script: No Change In Rates, Bond-Buying Program Even As Economy Improves

Spok Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPOK#NASDAQ">SPOK</a>) reported quarterly losses of $(0.04) per share. This is a 120 percent decrease over earnings of $0.20 per share from the same period last year. The company reported $35.72 million in sales this quarter. This is a 0.04 percent decrease over sales of $35.74 million the same period last year.

Spok Holdings Q2 EPS $(0.04) Down From $0.20 YoY, Sales $35.72M Down From $35.74M YoY

Contracts

PTGX

Protagonist Therapeutics Announced It Has Entered Into An Amended Collaboration Agreement With Janssen Biotech To Provide For The Concurrent Development Of Multiple Oral IL-23 Receptor Antagonists Against A Broad Range Of Implications

Zovio (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ZVO#NASDAQ">ZVO</a>) reported quarterly losses of $(0.02) per share which beat the analyst consensus estimate of $(0.05) by 60 percent. This is a 108.33 percent decrease over earnings of $0.24 per share from the same period last year. The company reported quarterly sales of $69.20 million which beat the analyst consensus estimate of $67.50 million by 2.52 percent. This is a 33.42 percent decrease over sales of $103.94 million the same period last year.

Zovio Q2 Adj. EPS $(0.02) Beats $(0.05) Estimate, Sales $69.20M Beat $67.50M Estimate

NuVasive (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NUVA#NASDAQ">NUVA</a>) reported quarterly earnings of $0.60 per share which beat the analyst consensus estimate of $0.44 by 36.36 percent. This is a 250 percent increase over losses of $(0.40) per share from the same period last year. The company reported quarterly sales of $294.80 million which beat the analyst consensus estimate of $285.08 million by 3.41 percent. This is a 44.79 percent increase over sales of $203.61 million the same period last year.

NuVasive Q2 EPS $0.60 Beats $0.44 Estimate, Sales $294.80M Beat $285.08M Estimate

Infrastructure and Energy (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IEA#NASDAQ">IEA</a>) reported quarterly earnings of $0.12 per share. This is a 33.33 percent increase over earnings of $0.09 per share from the same period last year.

Infrastructure and Energy Q2 EPS $0.12 Up From $0.09 YoY

Service Corp Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SCI#NYSE">SCI</a>) reported quarterly earnings of $0.92 per share which beat the analyst consensus estimate of $0.67 by 37.31 percent. This is a 58.62 percent increase over earnings of $0.58 per share from the same period last year. The company reported quarterly sales of $987.50 million which beat the analyst consensus estimate of $854.20 million by 15.61 percent. This is a 20.42 percent increase over sales of $820.03 million the same period last year.

Service Corp Intl Q2 EPS $0.92 Beats $0.67 Estimate, Sales $987.50M Beat $854.20M Estimate

PPD (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PPD#NASDAQ">PPD</a>) reported quarterly earnings of $0.39 per share which beat the analyst consensus estimate of $0.33 by 18.18 percent. This is a 56 percent increase over earnings of $0.25 per share from the same period last year. The company reported quarterly sales of $1.58 billion which beat the analyst consensus estimate of $1.32 billion by 19.39 percent. This is a 55.89 percent increase over sales of $1.01 billion the same period last year.

PPD Q2 Adj. EPS $0.39 Beats $0.33 Estimate, Sales $1.58B Beat $1.32B Estimate

ENSG

Ensign Group Raises FY21 EPS Guidance From $3.54-$3.66 To $3.55-$3.67 Vs Est. $3.60; Sees FY21 Revs $2.62B-$2.69B Vs Est. $2.64B

ServiceNow Sees Q3 Subscription Billings $1.32B-$1.325B

TTEK

UPDATE: Tetra Tech Raises FY21 EPS Guidance From $3.45-$3.60 To $3.69-$3.74 vs $3.70 Estimate, Sales From $2.4B-$2.55B To $2.5B-$2.55B vs $2.49B Est.

U.S. indices were trading higher going into the close Wednesday after the&nbsp;Federal Reserve left rates unchanged and said the economy continues to show strength, with inflation being transitory. U.S. infrastructure optimism has also lifted sentiment.
<ul>
<li>The Invesco QQQ Trust Series 1 (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/qqq#NASDAQ">QQQ</a>) finished higher by 0.38% to $365.83</li>
<li>The SPDR Dow Jones Industrial Average ETF Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/dia#NASDAQ">DIA</a>) fell by 0.36% to $349.36</li>
<li>The SPDR S&amp;P 500 ETF Trust (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/spy#NASDAQ">SPY</a>) finished lower by 0.04% to $438.83</li>
</ul>
Here are the day&#39;s winners and losers from the QQQ, according to data from <a href="https://pro.benzinga.com/">Benzinga Pro</a>.
NetEase Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/ntes#NASDAQ">NTES</a>), JD.Com Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/jd#NASDAQ">JD</a>) and Advanced Micro Devices, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/amd#NASDAQ">AMD</a>) were among the top gainers for the Nasdaq.
Sirius XM Holdings Inc (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/siri#NASDAQ">SIRI</a>), Starbucks Corporation (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/sbux#NASDAQ">SBUX</a>) and Mondelez (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/mdlz#NASDAQ">MDLZ</a>) were among the top losers for the QQQ.
<h3>Elsewhere On The Street</h3>
Apple, Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/aapl#NASDAQ">AAPL</a>) reported solid quarterly results Tuesday, with strength evident across the board. Wedbush analyst Daniel Ives maintained an Outperform rating and $185 price target for Apple shares&hellip; <a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/07/22203954/4-apple-analysts-react-to-q3-earnings-we-are-buyers-on-any-near-term-weakness">Read More</a>
AMC Entertainment Holdings Inc. (NYSE: <a class="ticker" href="https://www.benzinga.com/stock/amc#NYSE">AMC</a>) shares traded higher Wednesday after retail traders were able to push the stock higher&hellip; <a href="https://www.benzinga.com/trading-ideas/long-ideas/21/07/22205072/why-it-could-be-do-or-die-time-for-amc-bears">Read More</a> 
During the week of a highly anticipated IPO expected to value the company in the $35 billion range, Robinhood Markets Inc. (NASDAQ: <a class="ticker" href="https://www.benzinga.com/stock/hood#NASDAQ">HOOD</a>) is facing yet another in a long string of controversies surrounding its trading app&hellip; <a href="https://www.benzinga.com/analyst-ratings/analyst-color/21/07/22204882/robinhood-discloses-new-regulatory-probe-one-day-before-ipo">Read More</a>

After-Hours Center

AAPL

SPDR Dow Jones Industrial Average ETF Trust

HOOD

MDLZ

NTES

SBUX

SIRI

Netease And AMD Soar As The QQQ Finishes Higher Wednesday

This week&rsquo;s IPO lineup could feature a double digit number of companies hitting the public. Here is a look at some of the largest and most high profile companies going public this week.

AMTD Digital: Asian digital solutions platform AMTD Digital (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/HKD#NYSE">HKD</a>) <a href="https://www.sec.gov/Archives/edgar/data/1809691/000119312521184382/d943653df1a.htm">offers </a>risk solutions and digital insurance technology for partners. The company had revenue of $21.6 million in fiscal 2020 and $18.8 million through the first nine months of the current fiscal year. The company plans to sell 16 million ADSs at a price point of $6.80 to $8.20.

Molecular Partners: Clinical stage biotechnology company Molecular Partners (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOLN#NASDAQ">MOLN</a>) is <a href="https://www.sec.gov/Archives/edgar/data/1745114/000162828021011854/molecularpartnersf-1a3.htm">focused </a>on using its pioneering DARPin product in categories including infectious diseases, oncology and ophthalmology. The company partnered with Novartis (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NVS#NYSE">NVS</a>) in 2020, Amgen Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMGN#NASDAQ">AMGN</a>) in 2018 and AbbVie Inc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ABBV#NYSE">ABBV</a>) in 2011. Novartis owns 6% of the company. Molecular Partners plans to sell 3 million ADS.

Related Link:<a href="https://www.benzinga.com/news/21/06/21452966/ipo-preview-marqeta-taskus-monday-com-lead-busy-week-with-8-planned-public-listings"> IPO Preview: Marqeta, TaskUs, Monday.com Lead Busy Week With 8 Planned Public Listings&nbsp;</a>

WalkMe: With a mission to change the way humans interact with technology, WalkMe (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WKME#NASDAQ">WKME</a>) <a href="https://www.sec.gov/Archives/edgar/data/1847584/000119312521183894/d143770df1a.htm">offers </a>solutions for organizations. The company has many well-known companies as customers including Nestle and Veolia, two large European companies listed as case studies in the filing.

WalkMe had revenue of $148 million in 2020 and revenue of $42.7 million in the first quarter of 2021. The company&rsquo;s revenue was up 34% year-over-year in the last twelve months. The company has 368 customers that represent $100,000 or more in annual revenue and 22 customers that represent $1 million or more in annual revenue. WalkMe plans on selling 9.25 million shares at a price point of $29 to $32.

Convey Holding: Health care company Convey Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNVY#NYSE">CNVY</a>) <a href="https://www.sec.gov/Archives/edgar/data/1787640/000110465921077574/tm2037461-12_s1a.htm">partners </a>with eight of the 10 largest Medicare Advantage companies in the U.S. The company had 2.5 million Medicare Advantage and 1.6 million Prescription Drug Plan members in 2020. Revenue in 2020 for the company was $282.9 million. First-quarter 2021 revenue was $82.6 million for the company. Convey Holding plans to sell 13.3 million shares at a price point of $14 to $16.

Angel Oak Mortgage: Real estate finance company Angel Oak Mortgage&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AOMR#NYSE">AOMR</a>)&nbsp; <a href="https://www.sec.gov/Archives/edgar/data/1766478/000104746921001177/a2243276zs-11a.htm">acquires </a>and invests in first&nbsp;lien non-QM Loans and other mortgage assets in the U.S. The company had assets of $534.9 million at the end of the first quarter of 2021. The company has elected to be taxed as a REIT. Angel Oak Mortgage is seeking to sell 8.1 million shares at a price point of $20 to $21.

Lyell Immunopharma: Seeking to disrupt the T-cell reprogramming market, Lyell ImmunoPharma (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LYEL#NASDAQ">LYEL</a>) <a href="https://www.sec.gov/Archives/edgar/data/1806952/000119312521185918/d168165ds1a.htm">intends </a>to have four INDs submitted by the end of 2022. The company partnered with GlaxoSmithKline (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GSK#NYSE">GSK</a>) in 2019 in a deal good for up to $400 million in additional milestones after a $45-million upfront payment.

GlaxoSmithKline owns 14% of Lyell and Bristol-MyersSquibb (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BMY#NYSE">BMY</a>) owned Celgene owns 5% of the company. Lyell is planning to sell 25 million shares at a price point of $16 to $18.

Verve Therapeutics: Genetic medicine company Verve Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/VERV#NASDAQ">VERV</a>) is <a href="https://www.sec.gov/Archives/edgar/data/1840574/000119312521189442/d140009ds1a.htm">focused </a>on cardiovascular disease. The company plans to sell 11.8 million shares at a price point of $16 to $18.

Atai Life Sciences: <a href="https://www.benzinga.com/markets/cannabis/21/06/21533555/peter-thiel-backed-psychedelic-firm-atai-sets-terms-for-us-ipo-sees-2-3b-valuation">Backed </a>by Palantir Technologies (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PLTR#NYSE">PLTR</a>) and Paypal Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PYPL#NASDAQ">PYPL</a>) founder Peter Thiel, Atai Life Sciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATAI#NASDAQ">ATAI</a>) could be one of the high profile IPOs of the week.

The company is <a href="https://www.sec.gov/Archives/edgar/data/1840904/000119312521188243/d39052ds1a.htm">developing </a>treatment options for mental health disorders. The company has 10 programs in its pipeline and six enabling technologies. The company is planning on selling 14.3 million shares at a price point of $13 to $15.

AiHui Shou International: Pre-owned consumer electronics reseller AiHuiShou International (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) <a href="https://www.sec.gov/Archives/edgar/data/1838957/000119312521188965/d893059df1a.htm">seeks </a>to give a second life to all idle goods.

The company&rsquo;s three business lines &mdash; AHS Recycle, PJUT Marketplace and PaiPai Marketplace &mdash; help the company as the market leader in China with a market share of 6.6%. The company had revenue of $741.5 million in 2020 and $231.1 million in the first quarter of 2021, up 119% year-over-year. JD.com (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JD#NASDAQ">JD</a>) will own 32.3% of the company after the IPO. The company plans on selling 16.2 million ADSs at a price point of $13 to $15.

Previews

IPOs

Trading Ideas

IPO Preview: WalkMe, Atai Life Sciences Highlight Week Of Many Offerings

AiHuiShou International Co. Ltd. (&quot;ATRenew&quot; or the &quot;Company&quot;), a leading technology-driven pre-owned consumer electronics transactions and services platform in&nbsp;China, today announced the pricing of its initial public offering of 16,233,000 American Depositary Shares (&quot;ADSs&quot;), every three ADSs representing two Class A ordinary shares of the Company, at a price to the public of US$14.00&nbsp;per ADS, for a total offering size of&nbsp;approximately&nbsp;US$227 million, assuming the underwriters do not exercise their option to purchase additional ADSs. The ADSs are expected to begin trading on the New York Stock Exchange on&nbsp;June 18, 2021, under the symbol &quot;RERE.&quot; The closing of the offering is expected to occur on&nbsp;or about&nbsp;June 22, 2021, subject to the satisfaction of customary closing conditions.

The Company has granted the underwriters an option, exercisable within 30 days from the date of the final prospectus, to purchase up to an aggregate of 2,434,950 additional ADSs at US$14.00&nbsp;per ADS.

Goldman Sachs (Asia) L.L.C., BofA Securities, Inc., and China Renaissance Securities (Hong Kong) Limited are acting as the joint bookrunners of the offering. Guotai Junan Securities (Hong Kong) Limited, CLSA Limited, Tiger Brokers (NZ) Limited, CMB International Capital Limited, and Futu Inc. are acting as co-managers for the offering.

The Company&#39;s registration statements relating to the offering have has been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or a solicitation of an offer to buy the securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

The&nbsp;offering is being made only by means of a prospectus forming part of the effective registration&nbsp;statements. A copy of the final prospectus relating to the offering, when available, may be obtained from the following underwriters:

Goldman Sachs&nbsp;&amp; Co L.L.C. 
 
Attention: Prospectus Department 
 
200 West Street 
 
New York, NY&nbsp;10282-2198 
 
Phone: +1 (866) 471-2526 
 
Email:&nbsp;<a href="mailto:prospectus-ny@ny.email.gs.com" target="_blank">prospectus-ny@ny.email.gs.com</a>

BofA Securities, Inc. 
 
Attention: Prospectus Department 
 
NC1-004-03-43 
 
200 North College Street, 3rd Floor 
 
Charlotte, NC&nbsp;28255-0001 
 
United States of America 
 
Phone: +1 (800) 294-1322 
 
Email:&nbsp;<a href="mailto:dg.prospectus_requests@bofa.com" target="_blank">dg.prospectus_requests@bofa.com</a>

China Renaissance Securities (Hong Kong) Limited 
 
Attention: Prospectus Department 
 
Units&nbsp;8107-08,&nbsp;Level&nbsp;81,&nbsp;International&nbsp;Commerce&nbsp;Centre 
 
1&nbsp;Austin&nbsp;Road&nbsp;West,&nbsp;Kowloon,&nbsp;Hong Kong 
 
Phone: +852&nbsp;2287 1686 
 
Email:&nbsp;<a href="mailto:Guyu@chinarenaissance.com" target="_blank">Guyu@chinarenaissance.com</a>&nbsp;/&nbsp;<a href="mailto:dl-CRSyndicate@chinarenaissance.com" target="_blank">dl-CRSyndicate@chinarenaissance.com</a>

AiHuiShou International Announces Pricing Of IPO At $14/ADS

<ul>
	<li>Chinese technology-driven pre-owned consumer electronics transactions and services platform&nbsp;AiHuiShou International Co Ltd&nbsp;(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) priced 16.2 million ADSs at $14 per share to raise $227 million in its&nbsp;<a class="editor-rtfLink" href="https://www.benzinga.com/pressreleases/21/06/n21624400/aihuishou-international-co-ltd-announces-pricing-of-initial-public-offering" style="color:#4a6ee0; background:transparent; margin-top:0pt; margin-bottom:0pt" target="_blank">initial public offering</a>.</li>
	<li>Every three ADSs represent two shares.</li>
	<li>The shares are estimated to begin trading on the NYSE under the &ldquo;RERE&rdquo; symbol from today.</li>
	<li>The underwriters have a 30-day option to procure 2,434,950 additional ADSs.</li>
	<li>Goldman Sachs (Asia) L.L.C., BofA Securities, Inc., and China Renaissance Securities (Hong Kong) Limited are acting as the joint bookrunners of the offering.</li>
</ul>

Tech

Media

AiHuiShou International Prices IPO At $14 Per Share; Trading Begins Today

AiHuiShou International Shares Expected To Open For Trade Today; IPO Priced At $14/Share

<ul>
	<li>AiHuiShou International (RERE)</li>
	<li>Century Therapeutics (IPSC)</li>
	<li>ATAI Life Sciences (ATAI)</li>
	<li>Jaws Juggernaut Acquisition (JUGGU)</li>
	<li>Tremor International (TRMR)</li>
	<li>Ambrx Biopharma (AMAM)</li>
	<li>Cyteir Therapeutics (CYT)</li>
	<li>Codex DNA (DNAY)</li>
	<li>Femasys (FEMY)</li>
</ul>

List Of Initial Public Offerings For Friday, Jun. 18, 2021

AiHuiShou International Shares Open For Trade At $18.28; IPO Priced At $14/Share

<h3>Gainers</h3>

<ul>
	<li>Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) rose 47.2% to $56.86 in pre-market trading. CNH Industrial N.V</li>
	<li>(NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>) announced plans to acquire Raven Industries for $58 per share in cash.</li>
	<li>Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>) shares rose 38.8% to $8.70 in pre-market trading after jumping 16% on Friday.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) rose 15.6% to $2.74 in pre-market trading. Luokung Technology shares jumped 22% on Friday after the company announced its subsidiary eMapgo entered into a contract to deliver a new generation traffic control network and smart highway demonstration project for the Changjiu Expressway.</li>
	<li>Globus Maritime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) rose 11.5% to $5.64 in pre-market trading. Globus Maritime reported total comprehensive loss of $0.8 million for the first quarter, compared to $9 million loss in the year-ago period. Its voyage revenues surged to $5.2 million from $2.3 million.</li>
	<li>Caladrius Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLBS#NASDAQ">CLBS</a>) shares rose 9% to $1.70 in pre-market trading after declining 2% on Monday.</li>
	<li>TOMI Environmental Solutions, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TOMZ#NASDAQ">TOMZ</a>) rose 6.4% to $3.18 in pre-market trading. The company will join the Russell Microcap Index on June 28.</li>
	<li>ENGlobal Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENG#NASDAQ">ENG</a>) shares rose 5.7% to $2.79 in pre-market trading.</li>
	<li>OpGen, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OPGN#NASDAQ">OPGN</a>) rose 5.4% to $2.35 in pre-market trading. Last week, OpGen&rsquo;s CEO and COO bought shares of the company.</li>
	<li>ShiftPixy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIXY#NASDAQ">PIXY</a>) shares rose 5.3% to $2.61 in pre-market trading after dropping 2% on Friday.</li>
	<li>United Time Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) rose 5.1% to $17.65 in pre-market trading after gaining 4% on Friday.</li>
	<li>Orphazyme A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORPH#NASDAQ">ORPH</a>) rose 5% to $7.69 in pre-market trading. Orphazyme A S shares dipped around 50% on Friday after the company announced it received a Complete Response Letter from the FDA for its treatment for Niemann-Pick Disease Type C and also cut its FY2021 outlook.</li>
	<li>Aytu Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) rose 5% to $4.96 in pre-market trading after dropping around 5% on Friday.</li>
	<li>Euro Tech Holdings Company Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CLWT#NASDAQ">CLWT</a>) rose 4.3% to $3.43 in pre-market trading. Euro Tech, last week, declared $0.20 per share special dividend.</li>
</ul>

 
Find out what&#39;s going on in today&#39;s market and bring any questions you have to <a href="http://premarket.benzinga.com/pre-market-show/">Benzinga&#39;s PreMarket Prep</a>.

<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Theravance Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TBPH#NASDAQ">TBPH</a>) fell 11.5% to $15.51 in pre-market trading after the company reported results from Phase 2 study of nezulcitinib in patients hospitalized with acute lung injury due to COVID-19.</li>
	<li>Marathon Digital Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MARA#NASDAQ">MARA</a>) fell 7.4% to $26.79 in pre-market trading after declining 4% on Friday.</li>
	<li>Riot Blockchain, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RIOT#NASDAQ">RIOT</a>) fell 7% to $29.94 in pre-market trading. Compass Point initiated coverage on Riot Blockchain with a Buy rating and announced a price target of $43.</li>
	<li>AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares fell 6.2% to $16.14 in pre-market trading. AiHuiShou International, last week, priced its IPO at $14 per share.</li>
	<li>Pieris Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PIRS#NASDAQ">PIRS</a>) shares fell 5.7% to $3.33 in pre-market trading after declining 7% on Friday.</li>
	<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) fell 5.4% to $611.59 in pre-market trading. China Central Bank said banks and payment firms must not provide services including opening accounts, registration, transaction, clearing and settlement for cryptocurrency related speculations.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) fell 5.4% to $15.61 in pre-market trading after dropping around 12% on Friday.</li>
	<li>Cellect Biotechnology Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APOP#NASDAQ">APOP</a>) shares fell 5% to $3.73 in pre-market trading after declining around 6% on Friday.</li>
</ul>

Penny Stocks

Small Cap

Pre-Market Outlook

Movers

21 Stocks Moving in Monday's Pre-Market Session

Following the market opening Monday, the Dow traded up 1.27% to 33,712.27 while the NASDAQ rose 0.32% to 14,075.68. The S&amp;P also rose, gaining 0.87% to 4,202.85.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,541,990 cases with around 601,820 deaths. India confirmed a total of at least 29,935,220 cases and 388,130 deaths, while Brazil reported over 17,927,920 COVID-19 cases with 501,820 deaths. In total, there were at least 178,513,810 cases of COVID-19 worldwide with more than 3,866,730 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Energy shares surged by 2.5% on Monday. Meanwhile, top gainers in the sector included Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>), up 50%, and Dynagas LNG Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLNG#NYSE">DLNG</a>), up 14%.

 
In trading on Monday, communication services shares rose by just 0.3%.

 
Top Headline

CNH Industrial N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>) announced plans to acquire Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) for $58 per share in cash.

&nbsp;

 
Equities Trading UP

 
Lydall, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDL#NYSE">LDL</a>) shares shot up 82% to $60.60 after the company agreed to be acquired by Unifrax for $61.10 per share.

 
Shares of Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>) got a boost, shooting 52% to $9.55 after the company provided a business update on its proposed business combination timing and payment date for its preferred stock dividend.

 
Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) shares were also up, gaining 50% to $57.80 after CNH Industrial announced it will acquire the company for $58 per share in cash.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares tumbled 15% to $14.66. AiHuiShou International, last week, priced its IPO at $14 per share.

Shares of Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) were down 14% to $23.53.

United Time Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) was down, falling 12% to $14.63.

Commodities

 
In commodity news, oil traded up 0.3% to $71.84, while gold traded up 0.8% to $1,783.40.

 
Silver traded up 0.4% Monday to $26.065 while copper fell 0.6% to $4.1520.

 
Euro zone

European shares were higher today. The eurozone&rsquo;s STOXX 600 gained 0.3%, the Spanish Ibex Index rose 0.2% and the German DAX 30 gained 0.6%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.2%, French CAC 40 rose 0.3% and Italy&rsquo;s FTSE MIB gained 0.4%.

&nbsp;

Economics

The Chicago Fed National Activity Index rose to 0.29 in May versus a revised reading of -0.09 in April.

 
The Treasury is set to auction 3-and 6-month bills at 11:30 a.m. ET.

Eurozone

Global

Intraday Update

Mid-Morning Market Update: Markets Open Higher; CNH Industrial To Buy Raven Industries

<h3>Gainers</h3>

<ul>
	<li>Lydall, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDL#NYSE">LDL</a>) shares climbed 82.3% to $60.68 after the company agreed to be acquired by Unifrax for $61.10 per share.</li>
	<li>Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) shares jumped 49.6% to $57.79 after CNH Industrial announced it will acquire the company for $58 per share in cash.</li>
	<li>Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>) gained 45.6% to $9.13 after the company provided a business update on its proposed business combination timing and payment date for its preferred stock dividend.</li>
	<li>Alset EHome International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEI#NASDAQ">AEI</a>) jumped 41.5% to $6.95 after the company announced an agreement with Tesla for 20 Ehomes.</li>
	<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) gained 17.1% to $25.93 after the company reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett syndrome.</li>
	<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) gained 16.4% to $4.38 as the company announced that positive results from a Phase 2 trial of MN-166 (ibudilast) in alcohol use disorder (AUD) were published in Nature&#39;s Translational Psychiatry.</li>
	<li>1847 Goedeker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOED#NYSE">GOED</a>) gained 15.6% to $3.8500. 1847 Goedeker, last week, reported May 2021 sales of $44.3 million, up 41.9% year-on-year.</li>
	<li>Dynagas LNG Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLNG#NYSE">DLNG</a>) surged 13.5% to $3.1893. The company, last week, reported upbeat quarterly results.</li>
	<li>Aytu Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) rose 13.2% to $5.35 after dropping around 5% on Friday.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) rose 12.5% to $2.6650. Luokung Technology shares jumped 22% on Friday after the company announced its subsidiary eMapgo entered into a contract to deliver a new generation traffic control network and smart highway demonstration project for the Changjiu Expressway.</li>
	<li>Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) jumped 12.5% to $26.30. Smith &amp; Wesson Brands gained 17% on Friday after the company posted better-than-expected results for its fourth quarter.</li>
	<li>TaskUs, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TASK#NASDAQ">TASK</a>) gained 11.1% to $32.35. The company recently priced its IPO at $23 per share.</li>
	<li>Applied Molecular Transport Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMTI#NASDAQ">AMTI</a>) jumped 9.5% to $46.66.</li>
	<li>ENGlobal Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENG#NASDAQ">ENG</a>) shares climbed 9.5% to $2.89.</li>
	<li>ContextLogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISH#NASDAQ">WISH</a>) gained 8.8% to $12.40.</li>
	<li>Globus Maritime Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GLBS#NASDAQ">GLBS</a>) rose 5.2% to $5.33. Globus Maritime reported total comprehensive loss of $0.8 million for the first quarter, compared to $9 million loss in the year-ago period. Its voyage revenues surged to $5.2 million from $2.3 million.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares dipped 18.9% to $13.96. AiHuiShou International, last week, priced its IPO at $14 per share.</li>
	<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) fell 16.9% to $22.74.</li>
	<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) dropped 16.4% to $29.10 after the company reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in patients with Demodex blepharitis.</li>
	<li>Intec Pharma Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTEC#NASDAQ">NTEC</a>) fell 14.8% to $4.2250.</li>
	<li>BIT Mining Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) dropped 14.4% to $8.11. BIT Mining recently said it completed cash offer for shares of Loto Interactive.</li>
	<li>Tarena International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEDU#NASDAQ">TEDU</a>) declined 14.4% to $2.73.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) fell 13.4% to $14.28 after dropping around 12% on Friday.</li>
	<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) dipped 12.6% to $7.89.</li>
	<li>9F Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFU#NASDAQ">JFU</a>) dipped 10.9% to $2.36.</li>
	<li>AnPac Bio-Medical Science Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANPC#NASDAQ">ANPC</a>) fell 10.7% to $4.0897. The company recently announced it was granted its first disease treatment patent by the USPTO on June 7, 2021. The company also announced it cancer treatment project secured multi-million dollar funds.</li>
	<li>Amarin Corporation plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRN#NASDAQ">AMRN</a>) dropped 10.5% to $4.4350 after a report suggested the company was rejected in a Supreme Court bid to revive Vascepa patents.</li>
	<li>Future FinTech Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) declined 10% to $3.2650.</li>
	<li>Orphazyme A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORPH#NASDAQ">ORPH</a>) fell 9.3% to $6.65. Orphazyme A S shares dipped around 50% on Friday after the company announced it received a Complete Response Letter from the FDA for its treatment for Niemann-Pick Disease Type C and also cut its FY2021 outlook.</li>
	<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) fell 7.9% to $595.50. China Central Bank said banks and payment firms must not provide services including opening accounts, registration, transaction, clearing and settlement for cryptocurrency related speculations.</li>
	<li>United Time Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) fell 7.1% to $15.60.</li>
</ul>

31 Stocks Moving In Monday's Mid-Day Session

Midway through trading Monday, the Dow traded up 1.48% to 33,782.47 while the NASDAQ rose 0.74% to 14,134.01. The S&amp;P also rose, gaining 1.17% to 4,215.39.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,541,990 cases with around 601,820 deaths. India confirmed a total of at least 29,935,220 cases and 388,130 deaths, while Brazil reported over 17,927,920 COVID-19 cases with 501,820 deaths. In total, there were at least 178,513,810 cases of COVID-19 worldwide with more than 3,866,730 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Energy shares surged by 2.4% on Monday. Meanwhile, top gainers in the sector included Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>), up 32%, and Dynagas LNG Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLNG#NYSE">DLNG</a>), up 13%.

 
In trading on Monday, consumer discretionary shares rose by just 0.5%.

 
Top Headline

CNH Industrial N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>) announced plans to acquire Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) for $58 per share in cash.

&nbsp;

 
Equities Trading UP

 
Lydall, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDL#NYSE">LDL</a>) shares shot up 83% to $60.77 after the company agreed to be acquired by Unifrax for $61.10 per share.

 
Shares of Alset EHome International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEI#NASDAQ">AEI</a>) got a boost, shooting 36% to $6.69 after the company announced an agreement with Tesla for 20 Ehomes.

 
Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) shares were also up, gaining 49% to $57.67 after CNH Industrial announced it will acquire the company for $58 per share in cash.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares tumbled 19% to $14.01. AiHuiShou International, last week, priced its IPO at $14 per share.

Shares of Amarin Corporation plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRN#NASDAQ">AMRN</a>) were down 10% to $4.4950 after a report suggested the company was rejected in a Supreme Court bid to revive Vascepa patents.

Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) was down, falling 14% to $29.84 after the company reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in patients with Demodex blepharitis.

Commodities

 
In commodity news, oil traded up 1.5% to $72.69, while gold traded up 0.7% to $1,781.90.

 
Silver traded up 0.2% Monday to $26.025 while copper rose 0.6% to $4.1815.

 
Euro zone

European shares were higher today. The eurozone&rsquo;s STOXX 600 gained 0.67%, the Spanish Ibex Index rose 0.31% and the German DAX 30 gained 0.98%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.6%, French CAC 40 rose 0.56% and Italy&rsquo;s FTSE MIB gained 0.65 %.

&nbsp;

Economics

The Chicago Fed National Activity Index rose to 0.29 in May versus a revised reading of -0.09 in April.

Mid-Day Market Update: Crude Oil Rises 1.5%; Tarsus Pharmaceuticals Shares Slide

Toward the end of trading Monday, the Dow traded up 1.71% to 33,857.87 while the NASDAQ rose 0.63% to 14,119.16. The S&amp;P also rose, gaining 1.28% to 4,219.92.

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 33,541,990 cases with around 601,820 deaths. India confirmed a total of at least 29,935,220 cases and 388,130 deaths, while Brazil reported over 17,927,920 COVID-19 cases with 501,820 deaths. In total, there were at least 178,513,810 cases of COVID-19 worldwide with more than 3,866,730 deaths, according to data compiled by Johns Hopkins University.

 
Leading and Lagging Sectors

 
Energy shares surged by 4.1% on Monday. Meanwhile, top gainers in the sector included Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>), up 57%, and PEDEVCO Corp. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PED#NYSE">PED</a>), up 15%.

 
In trading on Monday, communication services shares rose by just 0.7%.

 
Top Headline

CNH Industrial N.V. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CNHI#NYSE">CNHI</a>) announced plans to acquire Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) for $58 per share in cash.

&nbsp;

 
Equities Trading UP

 
Lydall, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDL#NYSE">LDL</a>) shares shot up 86% to $61.82 after the company agreed to be acquired by Unifrax for $61.10 per share.

 
Shares of Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>) got a boost, shooting 57% to $9.85 after the company provided a business update on its proposed business combination timing and payment date for its preferred stock dividend.

 
Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) shares were also up, gaining 50% to $57.76 after CNH Industrial announced it will acquire the company for $58 per share in cash.

<a href="https://www.benzinga.com/movers">Check out these big movers of the day</a>

 
Equities Trading DOWN

AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares tumbled 14% to $14.80. AiHuiShou International, last week, priced its IPO at $14 per share.

Shares of Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) were down 15% to $23.34.

Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) was down, falling 16% to $29.21 after the company reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in patients with Demodex blepharitis.

Commodities

 
In commodity news, oil traded up 2.6% to $73.48, while gold traded up 0.9% to $1,784.70.

 
Silver traded up 0.4% Monday to $26.065 while copper rose 0.61% to $4.1825.

 
Euro zone

European shares closed higher today. The eurozone&rsquo;s STOXX 600 gained 0.70%, the Spanish Ibex Index rose 0.23% and the German DAX 30 gained 1%. Meanwhile, the London&rsquo;s FTSE 100 rose 0.64%, French CAC 40 rose 0.51% and Italy&rsquo;s FTSE MIB gained 0.71%.

 
Economics

The Chicago Fed National Activity Index rose to 0.29 in May versus a revised reading of -0.09 in April.

Mid-Afternoon Market Update: Dow Jumps Over 500 Points; Lydall Shares Spike Higher

<h3>Gainers</h3>

<ul>
	<li>Lydall, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LDL#NYSE">LDL</a>) shares jumped 85.4% to close at $61.72 on Monday after the company agreed to be acquired by Unifrax for $61.10 per share.</li>
	<li>New Concept Energy, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBR#NASDAQ">GBR</a>) gained 73.4% to settle at $9.40.</li>
	<li>Torchlight Energy Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TRCH#NASDAQ">TRCH</a>) rose 58.2% to close at $9.92 after the company provided a business update on its proposed business combination timing and payment date for its preferred stock dividend.</li>
	<li>Raven Industries, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RAVN#NASDAQ">RAVN</a>) shares surged 49.3% to settle at $57.65 after CNH Industrial announced it will acquire the company for $58 per share in cash.</li>
	<li>Moxian, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOXC#NASDAQ">MOXC</a>) jumped 46.8% to settle at $17.06 in sympathy with the overall market as it rebounded from last week&#39;s weakness following a shift in the Fed&#39;s policy.</li>
	<li>Alset EHome International Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AEI#NASDAQ">AEI</a>) gained 24.6% to close at $6.12 after the company announced an agreement with Tesla for 20 Ehomes.</li>
	<li>Mexco Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MXC#NYSE">MXC</a>) rose 21.7% to settle at $9.65.</li>
	<li>U.S. Energy Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/USEG#NASDAQ">USEG</a>) gained 21.1% to close at $5.06.</li>
	<li>ENGlobal Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ENG#NASDAQ">ENG</a>) shares surged 19.7% to close at $3.16.</li>
	<li>Kosmos Energy Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KOS#NYSE">KOS</a>) gained 19.1% to settle at $3.68. Bernstein upgraded Kosmos Energy from Market Perform to Outperform and raised the price target from $3.7 to $7.8.</li>
	<li>Aytu Biopharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AYTU#NASDAQ">AYTU</a>) jumped 19% to close at $5.63 after dropping around 5% on Friday.</li>
	<li>Smith &amp; Wesson Brands, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SWBI#NASDAQ">SWBI</a>) climbed 18.5% to settle at $27.68. Smith &amp; Wesson Brands gained 17% on Friday after the company posted better-than-expected results for its fourth quarter.</li>
	<li>ContextLogic Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WISH#NASDAQ">WISH</a>) jumped 18.4% to close at $13.50.</li>
	<li>1847 Goedeker Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOED#NYSE">GOED</a>) jumped 17.4% to close at $3.91. 1847 Goedeker, last week, reported May 2021 sales of $44.3 million, up 41.9% year-on-year.</li>
	<li>FIGS, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/FIGS#NYSE">FIGS</a>) gained 17.1% to close at $42.61 after various analysts initiated coverage on the stock with bullish ratings.</li>
	<li>ReShape Lifesciences Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RSLS#NASDAQ">RSLS</a>) jumped 15.6% to close at $6.29.</li>
	<li>Citius Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CTXR#NASDAQ">CTXR</a>) gained 14.6% to settle at $4.23.</li>
	<li>Laredo Petroleum, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/LPI#NYSE">LPI</a>) gained 14.4% to close at $75.06 in sympathy with the price of oil on increased demand.</li>
	<li>Anavex Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AVXL#NASDAQ">AVXL</a>) rose 13.7% to settle at $25.17 after the company reported a predictive biomarker response from its Phase 2 trial of ANAVEX2-73 (blarcamesine) in adult female patients with Rett syndrome.</li>
	<li>North American Construction Group Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NOA#NYSE">NOA</a>) gained 13.6% to close at $16.04 in sympathy with the price of oil on increased demand.</li>
	<li>Dynagas LNG Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DLNG#NYSE">DLNG</a>) climbed 12.8% to settle at $3.17. The company, last week, reported upbeat quarterly results.</li>
	<li>MediciNova, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MNOV#NASDAQ">MNOV</a>) rose 11.7% to close at $4.20 as the company announced that positive results from a Phase 2 trial of MN-166 (ibudilast) in alcohol use disorder (AUD) were published in Nature&#39;s Translational Psychiatry.</li>
	<li>Luokung Technology Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/LKCO#NASDAQ">LKCO</a>) gained 7.2% to close at $2.54. Luokung Technology shares jumped 22% on Friday after the company announced its subsidiary eMapgo entered into a contract to deliver a new generation traffic control network and smart highway demonstration project for the Changjiu Expressway.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>Code Chain New Continent Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCNC#NASDAQ">CCNC</a>) shares tumbled 20.7% to settle at $2.15 on Monday. Code Chain New Continent, earlier during the month, reported a joint venture with Zhongyou Technology, Ltd to &#39;pursue the development and operation of cryptocurrency mining with zero carbon footprint.&#39;</li>
	<li>GreenBox POS (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBOX#NASDAQ">GBOX</a>) fell 19% to close at $12.57.</li>
	<li>Intec Pharma Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NTEC#NASDAQ">NTEC</a>) shares dropped 16.9% to close at $4.12 on Monday.</li>
	<li>Tarsus Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TARS#NASDAQ">TARS</a>) shares fell 16.7% to close at $29.00 on Monday after the company reported topline data from Phase 2b/3 Saturn-1 trial evaluating TP-03 (lotilaner ophthalmic solution, 0.25%) in patients with Demodex blepharitis.</li>
	<li>GBS Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GBS#NASDAQ">GBS</a>) fell 15.7% to settle at $3.75.</li>
	<li>AnPac Bio-Medical Science Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ANPC#NASDAQ">ANPC</a>) fell 15.5% to close at $3.87. The company recently announced it was granted its first disease treatment patent by the USPTO on June 7, 2021. The company also announced it cancer treatment project secured multi-million dollar funds.</li>
	<li>AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) shares tumbled 15.4% to close at $14.56 on Monday. AiHuiShou International, last week, priced its IPO at $14 per share.</li>
	<li>Quest Resource Holding Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/QRHC#NASDAQ">QRHC</a>) fell 15.2% to close at $5.62. Quest Resource recently announced plans to acquire the assets of an Atlanta-based independent environmental services company.</li>
	<li>9F Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JFU#NASDAQ">JFU</a>) dipped 14.7% to close at $2.26.</li>
	<li>Aptevo Therapeutics Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/APVO#NASDAQ">APVO</a>) declined 14.3% to settle at $23.45.</li>
	<li>Red Cat Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RCAT#NASDAQ">RCAT</a>) dropped 13.9% to close at $2.41.</li>
	<li>Midatech Pharma plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MTP#NASDAQ">MTP</a>) dipped 13.85 to settle at $2.44.</li>
	<li>BIT Mining Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTCM#NYSE">BTCM</a>) fell 13.7% to close at $8.17. BIT Mining recently said it completed cash offer for shares of Loto Interactive.</li>
	<li>Tarena International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TEDU#NASDAQ">TEDU</a>) fell 13.2% to close at $2.77.</li>
	<li>Support.com, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRT#NASDAQ">SPRT</a>) fell 12.4% to settle at $3.52.</li>
	<li>Spruce Biosciences, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SPRB#NASDAQ">SPRB</a>) dropped 12.4% to close at $10.12. Spruce Biosciences recently reported publication of Phase 2 results for tildacerfont in the Journal of Clinical Endocrinology and Metabolism.</li>
	<li>Super League Gaming, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLGG#NASDAQ">SLGG</a>) fell 12.2% to settle at $5.10. Super League Gaming will join Russell Microcap Index, effective June 28.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) declined 11.8% to close at $14.56 after dropping around 12% on Friday.</li>
	<li>Future FinTech Group Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) fell 11.3% to close at $3.22.</li>
	<li>Qudian Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/QD#NYSE">QD</a>) slipped 11.2% to close at $2.38. Qudian, last week, reported worse-than-expected Q1 results.</li>
	<li>Orphazyme A/S (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORPH#NASDAQ">ORPH</a>) declined 11.1% to settle at $6.52. Orphazyme A S shares dipped around 50% on Friday after the company announced it received a Complete Response Letter from the FDA for its treatment for Niemann-Pick Disease Type C and also cut its FY2021 outlook.</li>
	<li>Alzamend Neuro, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ALZN#NASDAQ">ALZN</a>) fell 10.1% to settle at $8.12.</li>
	<li>MicroStrategy Incorporated (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSTR#NASDAQ">MSTR</a>) dipped 9.7% to settle at $583.67. China Central Bank said banks and payment firms must not provide services including opening accounts, registration, transaction, clearing and settlement for cryptocurrency related speculations.</li>
	<li>United Time Technology Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/UTME#NASDAQ">UTME</a>) slipped 6.7% to close at $15.67.</li>
	<li>Amarin Corporation plc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMRN#NASDAQ">AMRN</a>) fell 5.2% to close at $4.70 after a report suggested the company was rejected in a Supreme Court bid to revive Vascepa patents.</li>
</ul>

48 Biggest Movers From Yesterday

Stocks That Hit 52-Week Lows On Thursday

Goldman Sachs analyst Ronald Keung initiates coverage on AiHuiShou Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) with a Buy rating and announces Price Target of $20.8.

Price Target

Initiation

Analyst Ratings

Goldman Sachs Initiates Coverage On AiHuiShou Intl with Buy Rating, Announces Price Target of $20.8

Upgrades

Downgrades

Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021

B of A Securities initiates coverage on AiHuiShou Intl (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) with a Buy rating and announces Price Target of $20.

B of A Securities Initiates Coverage On AiHuiShou Intl with Buy Rating, Announces Price Target of $20

WIIM

Shares of several Chinese companies are trading lower on continued weakness amid regulatory concerns regarding education and technology companies.

Stocks That Hit 52-Week Lows On Tuesday

<h3>Gainers</h3>

<ul>
	<li>Oragenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NASDAQ">OGEN</a>) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that will enable it to pursue the rapid development of vaccines against SARS-CoV-2 and its variants.</li>
	<li>EyeGate Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEG#NASDAQ">EYEG</a>) shares climbed 48% to $4.62 after the company said it has entered a non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic specialty pharmaceutical company focused on using light sensitive &quot;photoswitch&quot; small molecules, specifically designed to restore vision in patients with inherited and age-related degenerative retinal diseases. The company also announced that Brian Strem, co-founder and managing director of Bayon Therapeutics, was appointed as permanent president, CEO and board member, effective immediately.</li>
	<li>ObsEva SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBSV#NASDAQ">OBSV</a>) shares jumped 29.6% to $3.27. Organon &amp; Co. and ObsEva announced the companies have entered into an agreement whereby Organon will license the global development, manufacturing and commercial rights to ebopiprant, an investigational compound being evaluated as a potential treatment for preterm labor by reducing inflammation and uterine contractions.</li>
	<li>Dyadic International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) gained 25% to $4.30 after the company reported technology transfer and licensing agreement with South Africa&#39;s Rubic Consortium aiming to &#39;develop and commercialize vaccines for distribution throughout the African continent.&#39;</li>
	<li>IRSA Propiedades Comerciales SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRCP#NASDAQ">IRCP</a>) gained 19% to $2.98.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) rose 18.6% to $2.92 as the company reported strong SMB user growth with over 2x new sign-ups.</li>
	<li>U.S. Physical Therapy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) surged 18.3% to $120.47. U.S. Physical Therapy is expected to release Q2 earnings on August 5.</li>
	<li>Eastside Distilling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) jumped 14.2% to $4.24.</li>
	<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) gained 13.3% to $8.45 after reporting Q2 results.</li>
	<li>APi Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>) shares rose 12.4% to $22.87. Carrier agreed to sell its Chubb Fire &amp; Security Business to APi Group Corporation for an enterprise value of $3.1 billion.</li>
	<li>Beyond Air, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) jumped 12.3% to $8.00.</li>
	<li>Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) surged 11.7% to $52.31 after the company posted upbeat Q2 results and raised FY21 guidance.</li>
	<li>Inovalon Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOV#NASDAQ">INOV</a>) gained 10.8% to $36.25. Nordic Capital is in advanced talks to acquire Inovalon Holdings Inc., Bloomberg reported.</li>
	<li>Orbsat Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSAT#NASDAQ">OSAT</a>) jumped 10.6% to $6.36. Orbsat recently announced its Global Telesat Communications unit has entered into an agreement with Alibaba.com. GTC will be a Gold-Supplier on the e-commerce website.</li>
	<li>TriNet Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NASDAQ">TNET</a>) gained 8.2% to $79.20 following Q2 results.</li>
	<li>The Aaron&#39;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) surged 7.1% to $29.68 after the company reported strong Q2 results and raised FY21 sales guidance.</li>
	<li>F5 Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose 5.9% to $203.90 after the company reported upbeat results for its third quarter. The company also said it sees Q4 adjusted earnings of $2.68 to $2.80 per share on sales of $660 million to $680 million.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) shares dipped 40.1% to $17.30. SkyWater Technology reported that it will invest $56 million in capacity expansion and gallium nitride technology.</li>
	<li>Infinity Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) fell 27.3% to $1.6146 after the company highlighted the presentation of updated data from Phase 2 MARIO-275 trial in urothelial cancer and Phase 2 MARIO-3 trial in triple negative breast cancer.</li>
	<li>Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) fell 24.9% to $6.66. Bit Digital shares jumped 110% on Monday after the company, and Digihost, announced they entered into a second strategic co-mining agreement.</li>
	<li>GasLog Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOP#NYSE">GLOP</a>) dipped 24% to $4.00 after reporting downbeat quarterly results.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) fell 19.4% to $10.80 after jumping over 54% on Monday.</li>
	<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) dropped 18.4% to $5.18.</li>
	<li>Code Chain New Continent Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCNC#NASDAQ">CCNC</a>) fell 18.1% to $1.76 after surging 13% on Monday.</li>
	<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) dipped 17.7% to $11.36. Faraday Future announced that all 300 of its invite-only FF 91 futurist alliance edition vehicles have been pre-ordered.</li>
	<li>Imv Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMV#NASDAQ">IMV</a>) fell 16.8% to $1.7050 after surging over 25% on Monday. IMV recently announced it priced a 14,285,714 unit offering at $1.75 per unit.</li>
	<li>SPAR Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGRP#NASDAQ">SGRP</a>) shares fell 16.3% to $1.85 after jumping around 28% on Monday.</li>
	<li>Minim, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) dropped 16.3% to $3.0550 after the company reported launch of $25 million common stock offering.</li>
	<li>AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) declined 15.2% to $11.08.</li>
	<li>ATI Physical Therapy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATIP#NYSE">ATIP</a>) dipped 15.1% to $4.0050 after various analysts downgraded the stock.</li>
	<li>NXT-ID Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTD#NASDAQ">NXTD</a>) fell 14.8% to $0.7670 after surging 15% on Monday.</li>
	<li>NanoVibronix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) fell 14.7% to $1.62. NanoVibronix recently said it shipped first order of PainShield Plus.</li>
	<li>Inozyme Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) dropped 14.3% to $16.45.</li>
	<li>Inozyme Pharma recently received orphan drug designation for INZ-701 from the European Medicines Agency for the treatment of ABCC6 deficiency.</li>
	<li>TRxADE HEALTH, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) fell 13% to $4.58 after the company reported a wider quarterly loss.</li>
	<li>Waterdrop Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) dropped 12.8% to $4.4080.</li>
	<li>Futu Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) fell 12.3% to $101.26 after declining around 7% on Monday.</li>
	<li>Future Fintech Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) shares fell 12.2% to $2.3450 after climbing 10% on Monday.</li>
	<li>Sos Ltd - ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOS#NYSE">SOS</a>) fell 11.9% to $2.6782 after climbing over 22% on Monday.</li>
	<li>Canaan Inc - ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) shares fell 11% to $5.95 after surging 16% on Monday.</li>
	<li>Cerecor Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CERC#NASDAQ">CERC</a>) shares fell 9.4% to $2.5199 after the company announced initial Phase 1b results for CERC-002 in moderate to severe Crohn&#39;s Disease patients.</li>
	<li>Morphosys Ag (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOR#NASDAQ">MOR</a>) shares fell 8.8% to $13.55. MorphoSys shares fell 8% on Monday after the company announced it updated financial guidance for 2021.</li>
	<li>Kiromic Biopharma Inc(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) shares fell 8.6% to $2.86 after the company said it has completed the acquisition of InSilico Solutions.</li>
	<li>Powerbridge Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) fell 8.1% to $1.2499 after the company announced it will build a supply chain management SaaS platform based on blockchain technology.</li>
	<li>Tyme Technologies Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TYME#NASDAQ">TYME</a>) fell 7.5% to $1.2762. Tyme Technologies shares surged around 28% on Monday after the company announced the USPTO has granted additional patent claims related to the company&#39;s metabolomic technology platform.</li>
</ul>

44 Stocks Moving In Tuesday's Mid-Day Session

<h3>Gainers</h3>

<ul>
	<li>Intrusion Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INTZ#NASDAQ">INTZ</a>) shares surged 52.1% to settle at $5.14 on Tuesday. Intrusion recently issued worse-than-expected preliminary Q2 sales results and announced the departure of its CEO.</li>
	<li>Oragenics, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OGEN#NASDAQ">OGEN</a>) shares jumped 34.1% to close at $0.8388 on Tuesday after the company announced it entered into a licensing agreement with the National Research Council of Canada that will enable it to pursue the rapid development of vaccines against SARS-CoV-2 and its variants.</li>
	<li>SGOCO Group, Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SGOC#NASDAQ">SGOC</a>) rose 29.6% to settle at $11.00.</li>
	<li>BiondVax Pharmaceuticals Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BVXV#NASDAQ">BVXV</a>) surged 26.9% to close at $3.44. The company, last month, reported a narrower quarterly loss.</li>
	<li>TAL Education Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TAL#NYSE">TAL</a>) rose 25.2% to settle at $5.51, rebounding after the Chinese education sector dipped on Monday following a policy from the Chinese government which may force for-profit education companies to become non-profit.</li>
	<li>EyeGate Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EYEG#NASDAQ">EYEG</a>) shares gained 20.8% to close at $3.77 after the company said it has entered a non-binding letter of intent to acquire Bayon Therapeutics, a private ophthalmic specialty pharmaceutical company focused on using light sensitive &quot;photoswitch&quot; small molecules, specifically designed to restore vision in patients with inherited and age-related degenerative retinal diseases. The company also announced that Brian Strem, co-founder and managing director of Bayon Therapeutics, was appointed as permanent president, CEO and board member, effective immediately.</li>
	<li>IRSA Propiedades Comerciales SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IRCP#NASDAQ">IRCP</a>) climbed 20.4% to settle at $3.01.</li>
	<li>Jiuzi Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/JZXN#NASDAQ">JZXN</a>) gained 19.2% to close at $3.98.</li>
	<li>NanoViricides, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NNVC#NYSE">NNVC</a>) rose 17.4% to settle at $4.92.</li>
	<li>U.S. Physical Therapy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/USPH#NYSE">USPH</a>) jumped 17.4% to settle at $119.50. U.S. Physical Therapy is expected to release Q2 earnings on August 5.</li>
	<li>Gaotu Techedu Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GOTU#NYSE">GOTU</a>) gained 15.6% to close at $2.89.</li>
	<li>Celestica Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLS#NYSE">CLS</a>) jumped 15.3% to close at $8.60 after reporting Q2 results.</li>
	<li>Orbsat Corp (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OSAT#NASDAQ">OSAT</a>) climbed 15.1% to settle at $6.62. Orbsat recently announced its Global Telesat Communications unit has entered into an agreement with Alibaba.com. GTC will be a Gold-Supplier on the e-commerce website.</li>
	<li>ObsEva SA (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/OBSV#NASDAQ">OBSV</a>) shares gained 13.9% to close at $2.87. Organon &amp; Co. and ObsEva announced the companies have entered into an agreement whereby Organon will license the global development, manufacturing and commercial rights to ebopiprant, an investigational compound being evaluated as a potential treatment for preterm labor by reducing inflammation and uterine contractions.</li>
	<li>Dyadic International, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/DYAI#NASDAQ">DYAI</a>) rose 13.1% to close at $3.89 after the company reported technology transfer and licensing agreement with South Africa&#39;s Rubic Consortium aiming to &#39;develop and commercialize vaccines for distribution throughout the African continent.&#39;</li>
	<li>Inovalon Holdings, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INOV#NASDAQ">INOV</a>) surged 13% to close at $36.95. Nordic Capital is in advanced talks to acquire Inovalon Holdings Inc., Bloomberg reported.</li>
	<li>Dingdong (Cayman) Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/DDL#NYSE">DDL</a>) gained 12.5% to settle at $22.40. Morgan Stanley initiated coverage on Dingdong (Cayman) with an Overweight rating and announced a price target of $28.</li>
	<li>Flora Growth Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FLGC#NASDAQ">FLGC</a>) rose 12.2% to close at $5.07. The Miami-based cannabis producer confirmed Tuesday it has signed a non-binding letter of intent to create a joint venture, through which it will handle registration, sales and distribution of KaLaya products in Colombia, Mexico and other Latin American countries.</li>
	<li>Turning Point Brands, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/TPB#NYSE">TPB</a>) climbed 10.5% to close at $51.73 after the company posted upbeat Q2 results and raised FY21 guidance.</li>
	<li>Beyond Air, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XAIR#NASDAQ">XAIR</a>) climbed 10.4% to settle at $7.86.</li>
	<li>Repligen Corporation (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGEN#NASDAQ">RGEN</a>) rose 9.9% to close at $226.38 following quarterly results.</li>
	<li>Eastside Distilling, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EAST#NASDAQ">EAST</a>) gained 9.4% to close at $4.06.</li>
	<li>APi Group Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/APG#NYSE">APG</a>) shares gained 9.4% to close at $22.26. Carrier agreed to sell its Chubb Fire &amp; Security Business to APi Group Corporation for an enterprise value of $3.1 billion.</li>
	<li>The Aaron&#39;s Company, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AAN#NYSE">AAN</a>) climbed 8.7% to settle at $30.13 after the company reported strong Q2 results and raised FY21 sales guidance.</li>
	<li>TriNet Group, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TNET#NASDAQ">TNET</a>) rose 7.8% to close at $78.91 following Q2 results.</li>
	<li>Graphic Packaging Holding Company (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GPK#NYSE">GPK</a>) surged 7.2% to settle at $18.75 following strong quarterly sales.</li>
	<li>Exela Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/XELA#NASDAQ">XELA</a>) gained 6.5% to close at $2.62 as the company reported strong SMB user growth with over 2x new sign-ups.</li>
	<li>F5 Networks, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIV#NASDAQ">FFIV</a>) shares rose 6.2% to close at $204.57 after the company reported upbeat results for its third quarter. The company also said it sees Q4 adjusted earnings of $2.68 to $2.80 per share on sales of $660 million to $680 million.</li>
</ul>

 
<a href="https://www.benzinga.com/investing/best-penny-stocks/">Check out these big penny stock gainers and losers</a>

<h3>Losers</h3>

<ul>
	<li>SkyWater Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SKYT#NASDAQ">SKYT</a>) shares fell 45.4% to close at $15.75 on Tuesday. SkyWater Technology reported that it will invest $56 million in capacity expansion and gallium nitride technology.</li>
	<li>Bit Digital, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BTBT#NASDAQ">BTBT</a>) fell 33.6% to close at $5.89. Bit Digital shares jumped 110% on Monday after the company, and Digihost, announced they entered into a second strategic co-mining agreement.</li>
	<li>Infinity Pharmaceuticals, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INFI#NASDAQ">INFI</a>) dipped 31.5% to settle at $1.52 after the company highlighted the presentation of updated data from Phase 2 MARIO-275 trial in urothelial cancer and Phase 2 MARIO-3 trial in triple negative breast cancer.</li>
	<li>NanoVibronix Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NAOV#NASDAQ">NAOV</a>) fell 22.6% to close at $1.47. NanoVibronix recently said it shipped first order of PainShield Plus.</li>
	<li>The9 Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NCTY#NASDAQ">NCTY</a>) dropped 22.2% to close at $10.42 after jumping over 54% on Monday.</li>
	<li>Code Chain New Continent Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CCNC#NASDAQ">CCNC</a>) dropped 19.5% to settle at $1.73 after surging 13% on Monday.</li>
	<li>ATI Physical Therapy, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ATIP#NYSE">ATIP</a>) fell 19.1% to settle at $3.82 after various analysts downgraded the stock.</li>
	<li>Adagene Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADAG#NASDAQ">ADAG</a>) dipped 18.7% to close at $13.70. Adagene recently entered into a clinical trial collaboration and supply agreement with Merck &amp; Co Inc.</li>
	<li>Minim, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MINM#NASDAQ">MINM</a>) fell 18.6% to settle at $2.97 after the company reported launch of $25 million common stock offering.</li>
	<li>GasLog Partners LP (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GLOP#NYSE">GLOP</a>) fell 18.3% to settle at $4.30 after reporting downbeat quarterly results.</li>
	<li>NXT-ID Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXTD#NASDAQ">NXTD</a>) fell 17.6% to close at $0.7420 after surging 15% on Monday.</li>
	<li>Faraday Future Intelligent Electric Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FFIE#NASDAQ">FFIE</a>) fell 17% to close at $11.45. Faraday Future announced that all 300 of its invite-only FF 91 futurist alliance edition vehicles have been pre-ordered.</li>
	<li>Boqii Holding Limited (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BQ#NYSE">BQ</a>) dipped 16.9% to settle at $2.80 on continued weakness amid regulatory concerns regarding education and technology companies.</li>
	<li>BlueCity Holdings Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/BLCT#NASDAQ">BLCT</a>) dropped 16.7% to close at $5.14.</li>
	<li>Takung Art Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TKAT#NASDAQ">TKAT</a>) fell 16.7% to settle at $5.80.</li>
	<li>iClick Interactive Asia Group Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ICLK#NASDAQ">ICLK</a>) fell 16.4% to close at $5.30.</li>
	<li>Oramed Pharmaceuticals Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORMP#NASDAQ">ORMP</a>) dipped 16% to settle at $13.42. Oramed Pharmaceuticals recently announced several updates for its majority-owned company Oravax Medical Inc.</li>
	<li>180 Life Sciences Corp. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ATNF#NASDAQ">ATNF</a>) dropped 15.8% to close at $7.08.</li>
	<li>Waterdrop Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WDH#NYSE">WDH</a>) fell 15.4% to close at $4.28.</li>
	<li>AiHuiShou International Co. Ltd. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/RERE#NYSE">RERE</a>) fell 15.2% to close at $11.09.</li>
	<li>XPeng Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) shares declined 14.9% to settle at $34.70 on continued weakness amid regulatory concerns regarding education and technology companies.</li>
	<li>Peabody Energy Corporation (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BTU#NYSE">BTU</a>) fell 14.7% to close at $10.26 amid a dip in crude futures.</li>
	<li>Futu Holdings Ltd (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FUTU#NASDAQ">FUTU</a>) fell 14.5% to close at $98.74 after declining around 7% on Monday.</li>
	<li>Future Fintech Group Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/FTFT#NASDAQ">FTFT</a>) shares declined 13.9% to settle at $2.30 after climbing 10% on Monday.</li>
	<li>Sos Ltd - ADR (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SOS#NYSE">SOS</a>) fell 13.8% to close at $2.62 after climbing over 22% on Monday.</li>
	<li>Smart Share Global Limited (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/EM#NASDAQ">EM</a>) dropped 13.7% to settle at $4.16.</li>
	<li>Imv Inc (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/IMV#NASDAQ">IMV</a>) fell 12.2% to close at $1.80 after surging over 25% on Monday. IMV recently announced it priced a 14,285,714 unit offering at $1.75 per unit.</li>
	<li>Inozyme Pharma, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/INZY#NASDAQ">INZY</a>) dipped 11.3% to settle at $17.03. Inozyme Pharma recently received orphan drug designation for INZ-701 from the European Medicines Agency for the treatment of ABCC6 deficiency.</li>
	<li>Asana, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ASAN#NYSE">ASAN</a>) fell 11% to close at $66.00.</li>
	<li>TRxADE HEALTH, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MEDS#NASDAQ">MEDS</a>) declined 10.8% to close at $4.69 after the company reported a wider quarterly loss.</li>
	<li>Canaan Inc - ADR (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CAN#NASDAQ">CAN</a>) shares declined 10.6% to close at $5.97 after surging 16% on Monday.</li>
	<li>Kiromic Biopharma Inc(NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KRBP#NASDAQ">KRBP</a>) shares fell 8.6% to close at $2.86 after the company said it has completed the acquisition of InSilico Solutions.</li>
	<li>Morphosys Ag (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MOR#NASDAQ">MOR</a>) shares dropped 8% to settle at $13.66. MorphoSys shares fell 8% on Monday after the company announced it updated financial guidance for 2021.</li>
	<li>Powerbridge Technologies Co., Ltd. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PBTS#NASDAQ">PBTS</a>) fell 5.2% to settle at $1.29 after the company announced it will build a supply chain management SaaS platform based on blockchain technology.</li>
</ul>

62 Biggest Movers From Yesterday

Shares of several Chinese companies are trading higher, rebounding from weakness caused by regulatory concerns regarding education and technology companies, and also concerns over the U.S.-China relationship.

Q2 2021		Est.		Actual		Surprise
EPS		(EXPECTED)2021-08-23
REV		(EXPECTED)2021-08-23

Recent Quotes

Earnings

Analyst Ratings

Related Companies

AiHuiShou Intl Frequently Asked Questions

How do I buy AiHuiShou Intl (RERE) stock?

Who are AiHuiShou Intl's (RERE) competitors?

What is the target price for AiHuiShou Intl (RERE) stock?

Current Stock Price for AiHuiShou Intl (RERE)?

Does AiHuiShou Intl (RERE) pay a dividend?

When is AiHuiShou Intl (NYSE:RERE) reporting earnings?

Is AiHuiShou Intl (RERE) going to split?

What sector and industry does AiHuiShou Intl (RERE) operate in?